Viemed Healthcare (VMD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $9.75, +0.62% vs the prior close of $9.69.
- Volume 201.00K shares, 0.6x its 50-day average (light).
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
VMD rises 0.6% to $9.75, a 1-month high, 10 up days in a row. Closed at $9.75, +0.62% vs the prior close of $9.69. Day range $9.69–$9.87, opened at $9.71.
VMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — VMD rises 0.6% to $9.75, a 1-month high, 10 up days in a row
- Closed at $9.75, +0.62% vs the prior close of $9.69. Day range $9.69–$9.87, opened at $9.71.
- Volume was 201.00K shares, 0.6x its 50-day average of 349.53K — lighter than usual.
- Price is +7.1% vs its 50-day average ($9.10) and +3.4% vs its 200-day average ($9.43).
- 52-week range $6.05–$12.61; today's close sits at 56% of that range, 22.7% below the 52-week high.
- That makes 10 straight gains.
Oct 14, 2026 — VMD rises 0.8% to $9.69, a 1-month high, 9 up days in a row
- Closed at $9.69, +0.83% vs the prior close of $9.61. Day range $9.51–$9.69, opened at $9.55.
- Volume was 220.50K shares, 0.6x its 50-day average of 363.76K.
- Price is +6.5% vs its 50-day average ($9.10) and +2.9% vs its 200-day average ($9.42).
- 52-week range $6.05–$12.61; today's close sits at 55% of that range, 23.2% below the 52-week high.
- That makes 9 straight gains.
Oct 13, 2026 — VMD ends flat (+0.1%) to $9.61, a 1-month high, 8 up days in a row
- Closed at $9.61, +0.10% vs the prior close of $9.60. Day range $9.52–$9.67, opened at $9.63.
- Volume was 169.60K shares, 0.5x its 50-day average of 368.39K — lighter than usual.
- Price is +5.5% vs its 50-day average ($9.11) and +2.1% vs its 200-day average ($9.41).
- 52-week range $6.05–$12.61; today's close sits at 54% of that range, 23.8% below the 52-week high.
- That makes 8 straight gains.
Oct 12, 2026 — VMD rises 0.8% to $9.60, a 1-month high, 7 up days in a row
- Closed at $9.60, +0.84% vs the prior close of $9.52. Day range $9.32–$9.66, opened at $9.42.
- Volume was 151.10K shares, 0.4x its 50-day average of 374.45K — lighter than usual.
- Price is +5.0% vs its 50-day average ($9.15) and +2.2% vs its 200-day average ($9.40).
- 52-week range $6.05–$12.61; today's close sits at 54% of that range, 23.9% below the 52-week high.
- That makes 7 straight gains.
Oct 9, 2026 — VMD rises 1.2% to $9.52, a 1-month high, 6 up days in a row
- Closed at $9.52, +1.17% vs the prior close of $9.41. Day range $9.38–$9.54, opened at $9.38.
- Volume was 152.50K shares, 0.4x its 50-day average of 375.60K — lighter than usual.
- Price is +3.6% vs its 50-day average ($9.19) and +1.4% vs its 200-day average ($9.38).
- 52-week range $6.05–$12.61; today's close sits at 53% of that range, 24.5% below the 52-week high.
- That makes 6 straight gains.
Oct 8, 2026 — VMD rises 0.4% to $9.41, a 1-month high, 5 up days in a row
- Closed at $9.41, +0.43% vs the prior close of $9.37. Day range $9.26–$9.60, opened at $9.39.
- Volume was 268.60K shares, 0.7x its 50-day average of 374.14K.
- Price is +1.9% vs its 50-day average ($9.23) and +0.4% vs its 200-day average ($9.37).
- 52-week range $6.05–$12.61; today's close sits at 51% of that range, 25.4% below the 52-week high.
- That makes 5 straight gains.
Oct 7, 2026 — VMD rises 0.4% to $9.37, a 1-month high, 4 up days in a row
- Closed at $9.37, +0.43% vs the prior close of $9.33. Day range $9.32–$9.53, opened at $9.32.
- Volume was 366.60K shares, 1.0x its 50-day average of 370.77K.
- Price is +1.0% vs its 50-day average ($9.28) and +0.1% vs its 200-day average ($9.36).
- 52-week range $6.05–$12.61; today's close sits at 51% of that range, 25.7% below the 52-week high.
- That makes 4 straight gains.
Oct 6, 2026 — VMD rises 1.0% to $9.33, a 1-month high, 3 up days in a row
- Closed at $9.33, +0.97% vs the prior close of $9.24. Day range $9.20–$9.40, opened at $9.29.
- Volume was 260.50K shares, 0.7x its 50-day average of 370.70K.
- Price is +0.0% vs its 50-day average ($9.33) and -0.3% vs its 200-day average ($9.36).
- 52-week range $6.05–$12.61; today's close sits at 50% of that range, 26.0% below the 52-week high.
- That makes 3 straight gains.
Oct 5, 2026 — VMD rises 1.2% to $9.24, a 1-month high
- Closed at $9.24, +1.20% vs the prior close of $9.13. Day range $9.09–$9.30, opened at $9.15.
- Volume was 217.80K shares, 0.6x its 50-day average of 370.91K — lighter than usual.
- Price is -1.5% vs its 50-day average ($9.38) and -1.1% vs its 200-day average ($9.35).
- 52-week range $6.05–$12.61; today's close sits at 49% of that range, 26.7% below the 52-week high.
Oct 2, 2026 — VMD rises 0.6% to $9.13
- Closed at $9.13, +0.55% vs the prior close of $9.08. Day range $8.91–$9.17, opened at $9.17.
- Volume was 387.70K shares, 1.0x its 50-day average of 370.21K.
- Price is -3.2% vs its 50-day average ($9.44) and -2.2% vs its 200-day average ($9.34).
- 52-week range $6.05–$12.61; today's close sits at 47% of that range, 27.6% below the 52-week high.
VMD latest news & SEC filings
Every SEC filing by or about VMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 24, 2026 · SCHEDULE 13D/A — Update to a 13D 5%+ stake disclosure
Update to a 13D 5%+ stake disclosure
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 20, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 19, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Aug 5, 2026 · S-8 — Registration of shares for employee stock plans (S-8)
Registration of shares for employee stock plans (S-8)
Aug 3, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $78.10M (prior year $63.06M) (+23.9% vs Jun 30, 2025)
- Net income: $2.76M (prior year $3.16M) (-12.4% vs Jun 30, 2025)
- Diluted EPS: $0.07 (prior year $0.08) (-12.5% vs Jun 30, 2025)
Aug 3, 2026 · 8-K — Current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 24, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jun 26, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Frazier William sold 10,000 shares at $11.72 (≈$117.20K) on Jun 25, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Jun 26, 2026 · 4 — Insider trade report (Form 4)
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Smokoff Timothy sold 3,364 shares at $11.50 (≈$38.69K) on Jun 24, 2026
- Smokoff Timothy sold 5,000 shares at $11.56 (≈$57.80K) on Jun 24, 2026
- Smokoff Timothy sold 5,000 shares at $11.41 (≈$57.05K) on Jun 24, 2026
- Smokoff Timothy sold 1,636 shares at $11.48 (≈$18.78K) on Jun 24, 2026
- Smokoff Timothy sold 5,000 shares at $11.53 (≈$57.65K) on Jun 24, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Things to know before you trade VMD
- Last results release: Aug 3, 2026 (8-K Item 2.02). Previous ones: May 5, 2026, Mar 4, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Nov 2, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 0.89% (largest 2.2%). That is a relatively calm stock.
- Liquidity: about 253.60K shares (≈$2.47M) trade per day on average.
- 52-week position: $9.75 vs a range of $6.05–$12.61 (56% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 9 sales; latest: William Frazier sold 10,000 shares on Jun 25, 2026.
- Latest filings: 8-K Aug 20, 2026; 10-Q Aug 3, 2026; 8-K Aug 3, 2026.
- Share count: 38.09M shares outstanding (Jul 27, 2026), -1.8% vs a year earlier.
- Listing: Nasdaq · industry: Services-Misc Health & Allied Services, NEC.
VMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 9.71 | 9.87 | 9.69 | 9.75 | 201.00K |
| Oct 14, 2026 | 9.55 | 9.69 | 9.51 | 9.69 | 220.50K |
| Oct 13, 2026 | 9.63 | 9.67 | 9.52 | 9.61 | 169.60K |
| Oct 12, 2026 | 9.42 | 9.66 | 9.32 | 9.60 | 151.10K |
| Oct 9, 2026 | 9.38 | 9.54 | 9.38 | 9.52 | 152.50K |
| Oct 8, 2026 | 9.39 | 9.60 | 9.26 | 9.41 | 268.60K |
| Oct 7, 2026 | 9.32 | 9.53 | 9.32 | 9.37 | 366.60K |
| Oct 6, 2026 | 9.29 | 9.40 | 9.20 | 9.33 | 260.50K |
| Oct 5, 2026 | 9.15 | 9.30 | 9.09 | 9.24 | 217.80K |
| Oct 2, 2026 | 9.17 | 9.17 | 8.91 | 9.13 | 387.70K |
| Oct 1, 2026 | 9.08 | 9.20 | 9.03 | 9.08 | 265.00K |
| Sep 30, 2026 | 9.19 | 9.24 | 8.95 | 9.10 | 253.90K |
| Sep 29, 2026 | 9.01 | 9.24 | 8.96 | 9.23 | 230.80K |
| Sep 28, 2026 | 8.92 | 9.12 | 8.83 | 9.11 | 336.50K |
| Sep 25, 2026 | 8.81 | 8.93 | 8.71 | 8.91 | 199.80K |
| Sep 24, 2026 | 8.80 | 8.85 | 8.66 | 8.82 | 255.60K |
| Sep 23, 2026 | 8.95 | 8.97 | 8.78 | 8.80 | 213.40K |
| Sep 22, 2026 | 8.85 | 9.01 | 8.83 | 8.96 | 241.60K |
| Sep 21, 2026 | 8.90 | 8.97 | 8.69 | 8.85 | 265.00K |
| Sep 18, 2026 | 8.97 | 9.06 | 8.86 | 8.91 | 414.60K |
About Viemed Healthcare
Viemed Healthcare (VMD) is listed on the Nasdaq and classified by the SEC under “Services-Misc Health & Allied Services, NEC”. Its business address is in LAFAYETTE, LA. State of incorporation: British Columbia, Canada. Fiscal year ends December 31. SEC CIK 1729149.
VMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Randy E. Dobbs | Director | Aug 19, 2026 |
| William Frazier | Chief Medical Officer | Jun 26, 2026 |
| Sabrina Heltz | Director | Aug 19, 2026 |
| Casey Hoyt | Chief Executive Officer | Feb 2, 2026 |
| Nitin Kaushal | Director | Aug 19, 2026 |
| Timothy Smokoff | Director | Aug 19, 2026 |
| William Todd Zehnder | Chief Operating Officer | Feb 2, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jerome Cambre | Vice President of Sales | Feb 2, 2026 |
| Trae Fitzgerald | Chief Financial Officer | Feb 2, 2026 |
| William Frazier | Chief Medical Officer | Jun 26, 2026 |
| Casey Hoyt | Chief Executive Officer | Feb 2, 2026 |
| Michael Moore | President | Mar 20, 2026 |
| Jeremy Trahan | General Counsel | Feb 2, 2026 |
| William Todd Zehnder | Chief Operating Officer | Feb 2, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jun 25, 2026 | William Frazier | Sale | 10,000 | $11.72 |
| Jun 24, 2026 | Timothy Smokoff | Sale | 3,364 | $11.50 |
| Jun 24, 2026 | Timothy Smokoff | Sale | 5,000 | $11.56 |
| Jun 24, 2026 | Timothy Smokoff | Sale | 5,000 | $11.41 |
| Jun 24, 2026 | Timothy Smokoff | Sale | 1,636 | $11.48 |
| Jun 24, 2026 | Timothy Smokoff | Sale | 5,000 | $11.53 |
| Mar 20, 2026 | Michael Moore | Sale | 65,000 | $8.77 |
| Mar 19, 2026 | Michael Moore | Sale | 40,232 | $9.21 |
| Mar 18, 2026 | Michael Moore | Sale | 31,570 | $9.42 |
VMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $270.28M | $14.93M | 0.37 | $51.92M |
| Dec 31, 2024 | $224.26M | $11.27M | 0.28 | $39.09M |
| Dec 31, 2023 | $183.01M | $10.24M | 0.25 | $45.21M |
| Dec 31, 2022 | $138.83M | $6.22M | 0.16 | $27.75M |
| Dec 31, 2021 | $117.06M | $9.13M | 0.22 | $22.49M |
Latest balance sheet: total assets $204.22M, total liabilities $58.26M, cash $10.68M (as of Jun 30, 2026).
VMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 3, 2026 | 8-K Item 2.02 (results) | $11.69 |
| May 5, 2026 | 8-K Item 2.02 (results) | $9.70 |
| Mar 4, 2026 | 8-K Item 2.02 (results) | $9.08 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $6.43 |
| Aug 6, 2025 | 8-K Item 2.02 (results) | $6.45 |
| May 7, 2025 | 8-K Item 2.02 (results) | $7.27 |
| Mar 10, 2025 | 8-K Item 2.02 (results) | $7.40 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $9.14 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 6, 2024 | 8-K Item 2.02 (results) | — |
| Mar 6, 2024 | 8-K Item 2.02 (results) | — |
| Nov 1, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Services-Misc Health & Allied Services, NEC
Davita (DVA)Sotera Health (SHC)Fresenius Medical Care AG (FMS)Progyny (PGNY)agilon health (AGL)NewGenIvf (NIVF)Park Dental Partners (PARK)Mangoceuticals (MGRX)Cryo Cell International (CCEL)BioRestorative Therapies (BRTX)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on VMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.